All the news Showing 10 of 36 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Antihistamine use halved the risk of liver cancer in people with viral hepatitis Keith Alcorn / 08 February 2022 Antihistamines used for relief of allergies and hay fever halved the risk of developing hepatocellular carcinoma (HCC; liver cancer) in people with viral hepatitis during a ten-year follow-up period, a review of ... Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... Pancreatic and colorectal cancer risk raised in people with hepatitis C Keith Alcorn / 16 March 2021 Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer was more likely to occur in people diagnosed with hepatitis ... Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Immunotherapy combinations show promise for advanced liver cancer Liz Highleyman / 02 September 2020 Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer, according to a set of late-breaking presentations last week at the 2020 Digital ... Liver cancer risk after hepatitis C cure is lower in people with HIV Keith Alcorn / 24 August 2020 People with HIV who were cured of hepatitis C were less likely than HIV-negative people to develop hepatocellular carcinoma (HCC – liver cancer) in the three-and-a-half years after completing hepatitis C treatment, Spanish ... A healthy lifestyle could prevent most liver cancer and liver-related deaths Liz Highleyman / 17 December 2019 A healthy lifestyle, including smoking cessation, moderate drinking, a balanced diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer and deaths due to liver disease, according to a study ... Sustained response to HCV antivirals boosts liver cancer survival Liz Highleyman / 19 November 2019 People with liver cancer who achieved a sustained virological response (SVR) to direct-acting antiviral (DAA) therapy for hepatitis C saw a reduction in both liver-related and all-cause mortality over five years, according to ... When is the right time to treat hepatitis C in people with liver cancer? Keith Alcorn / 27 October 2019 Direct-acting antiviral treatment for hepatitis C need not be delayed until the completion of treatment for hepatocellular carcinoma (HCC; liver cancer), but people with hepatitis C need to be warned of a ... ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive